Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000438766 | SCV000535286 | uncertain significance | not provided | 2022-03-22 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function |
Invitae | RCV001861639 | SCV002169373 | benign | Adams-Oliver syndrome 5 | 2023-10-17 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001861639 | SCV002553294 | uncertain significance | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002270478 | SCV002553295 | uncertain significance | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002374721 | SCV002667549 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2021-11-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV002374721 | SCV003838459 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2021-11-24 | criteria provided, single submitter | clinical testing |